CEACAM5 and cancer: By univariate analysis, the poor prognostic factors included a high cfDNA level > 6687 copies/mL (cut-off value based on the median cfDNA level for total patients), positive lymph node involvement, abnormal serum CEA level > 5 ng/mL, and advanced stage II and III cancer.